|
|
| Research article summary (published 3 Mar 2007): |
Implications for neurobiological research of cognitive models of psychosis: a theoretical paper.
Full Abstract
BACKGROUND:
Cognitive models of the positive symptoms of psychosis specify the cognitive, social and emotional processes hypothesized to contribute to their occurrence and persistence, and propose that vulnerable individuals make characteristic appraisals that result in specific positive symptoms.
METHOD:
We describe cognitive models of positive psychotic symptoms and use this as the basis of discussing recent relevant empirical investigations and reviews that integrate cognitive approaches into neurobiological frameworks.
RESULTS:
Evidence increasingly supports a number of the hypotheses proposed by cognitive models. These are that:
psychosis is on a continuum; specific cognitive processes are risk factors for the transition from subclinical experiences to clinical disorder; social adversity and trauma are associated with psychosis and with negative emotional processes; and these emotional processes contribute to the occurrence and persistence of psychotic symptoms. There is also evidence that reasoning biases contribute to the occurrence of delusions.
CONCLUSIONS:
The benefits of incorporating cognitive processes into neurobiological research include more sophisticated, bidirectional and interactive causal models, the amplification of phenotypes in neurobiological investigations by including emotional processes, and the adoption of more specific clinical phenotypes. For example, there is potential value in studying gene x environment x cognition/emotion interactions. Cognitive models and their derived phenotypes constitute the missing link in the chain between genetic or acquired biological vulnerability, the social environment and the expression of individual positive symptoms.
Learn Faster Today Improve your study skills
Author information
Author/s: Garety, Philippa A (PA); Bebbington, Paul (P); Fowler, David (D); Freeman, Daniel (D); Kuipers, Elizabeth (E);
Affiliation: Department of Psychology, Institute of Psychiatry, King's College London, London, UK. p.garety(-atsign-)iop.kcl.ac.uk
Grants: 062452 (Agency:Wellcome Trust)
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal: Psychological medicine (Psychol Med), published in England. (Language: eng)
Reference: 2007-Oct; vol 37 (issue 10) : pp 1377-91
Dates: Created 2007/09/12; Completed 2008/02/04;
PMID: 17335638, status: MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
These are the highest related articles currently in the database:
- The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients.
30 Jul 2007 - Diffusion tensor imaging demonstrates fiber impairment in Susac syndrome.
22 Oct 2007 - Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
20 Jan 2008 - Neuropsychological rehabilitation.
30 Dec 2007 - Cognitive functions after only one ECT session: a controlled study.
12 Feb 2008 - [Permanent psychiatric effects in former addicts to marijuana or stimulants]
30 Dec 2007 - Interventions for cognitive deficits in adults with brain tumours.
30 May 2008 - Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial.
31 May 2008 - Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial.
9 Jul 2007 - Rehabilitation of executive functioning after focal damage to the cerebellum.
28 Jul 2007
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.